SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-018578
Filing Date
2017-03-22
Accepted
2017-03-22 14:46:17
Documents
6
Period of Report
2017-03-22
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-4288_68k.htm 8-K 45863
2 EX-4.2 a17-4288_6ex4d2.htm EX-4.2 38095
3 EX-4.3 a17-4288_6ex4d3.htm EX-4.3 39045
4 EX-4.4 a17-4288_6ex4d4.htm EX-4.4 38752
5 EX-4.5 a17-4288_6ex4d5.htm EX-4.5 38782
6 EX-4.6 a17-4288_6ex4d6.htm EX-4.6 38739
  Complete submission text file 0001104659-17-018578.txt   240393
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 17706437
SIC: 2834 Pharmaceutical Preparations